Determining the survival benefit of postoperative radiotherapy in patients with pT1-3N1M0 rectal cancer undergoing total mesorectal excision: a retrospective analysis

BACKGROUND: The National Comprehensive Cancer Network guidelines recommend routine postoperative adjuvant radiotherapy and chemotherapy for patients with stage III rectal cancer who do not receive neoadjuvant therapy before surgery. The present study aimed to evaluate the value of postoperative radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jin-hu, Ye, Qing, Huang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037866/
https://www.ncbi.nlm.nih.gov/pubmed/36959560
http://dx.doi.org/10.1186/s12876-023-02697-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037866/
https://www.ncbi.nlm.nih.gov/pubmed/36959560
http://dx.doi.org/10.1186/s12876-023-02697-4

Ejemplares similares